Ask AI about PharmAbcine
Post your question publicly — other visitors, and whoever manages this page, can answer. It will be visible on this page.
Want to hear about this company again? Follow it and we’ll email you when a new review appears.
AI-generated from reviews on this page. Verify anything important with the company directly.
0 Reviews
Italiano
No reviews
Questions & Answers
No questions yet — be the first to ask.
Sign in to post
Your text is saved — you'll come right back to post.
Don't have an account? Create one
News & Press
No news yet. This is where the business shares its own updates and press.
Photos
No photos yet. Photos shared by reviewers will show up here.
About PharmAbcine
PharmAbcine is a specialized biotech company that develops fully human therapeutic monoclonal antibody (mAb) using innovative discovery technology and excellent human resources for the treatment of human diseases, such as cancer and inflammatory diseases. Our mission is to develop a first-in-class and best-in-class mAb for those target diseases.
PharmAbcine's business is mainly focused on out-licensing of candidate therapeutics and clinical application.
For this purpose, we builds competitive pipelines & drug discovery platform by in-house approach. When necessary, we consider extending strategic partnership for win-win business model.
Our management team has expertise in all aspects of therapeutic antibody discovery and development, including marketing and we are also supported by world-class scientific advisors who are thought leaders in biology and medicine.
- Website
- pharmabcine.com
